Hutch News

Hutch News

Stories tagged 'cancer vaccine'

The latest in gynecological cancer research from the Pacific Northwest

Inaugural Northwest Gynecological Cancer Symposium brings together scientists studying ovarian, cervical and endometrial cancers

Dec. 6, 2017 | By Rachel Tompa / Fred Hutch News Service

Monday, cancer researchers from around the Pacific Northwest gathered at Fred Hutchinson Cancer Research Center to discuss their latest efforts to better prevent, detect and treat cancers of the female reproductive tract in the inaugural Northwest Gynecological Cancer Symposium.

View story >

Teacher, mom — and living proof of principle

Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.

Sept. 8, 2017 | By Susan Keown / Fred Hutch News Service

When Tiffany's advanced cancer kept coming back, she decided to become the first person in the world to receive a still-experimental new immunotherapy.

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 14, 2016

Good News: Drs. Harmit Malik, Jesse Bloom win ASM awards; Fred Hutch team launches personalized anticancer vaccine project

View story >

More early cervical cancer cases being detected under Affordable Care Act

New study finds higher rates of young women covered by parents' private insurance being diagnosed, treated earlier

Nov. 24, 2015 | By Diane Mapes / Fred Hutch News Service

A new study suggests that young women covered under the Affordable Care Act are finding, and treating, their cervical cancers earlier. A Fred Hutch expert weighs in.

View story >

1 in 10 women is not being screened for cervical cancer

As with the HPV vaccine, a key barrier is 'missed opportunities' among doctors

Nov. 5, 2014 | By Mary Engel / Fred Hutch News Service

Cervical cancer screening has been considered one of the great success stories in cancer prevention, yet about 8 million U.S. women have not been screened for the disease in the last five years, according to a report released today by the U.S. Centers for Disease Control and Prevention. "The United States is going to be the shame of the developed world because our rates of [HPV vaccine] uptake are so much lower than other countries," said Fred Hutch's Dr. Denise Galloway, whose research helped lay the groundwork for the vaccine.

View story >

The HPV cancer vaccine: Are two doses as good as three?

A reduced dosing regimen may increase vaccination adherence, decrease costs

Aug. 26, 2014 | By Diane Mapes / Fred Hutch News Service

How do you get more people to take advantage of the cancer-busting HPV vaccine? One way might be to lower the number of doses, a hot topic among public health researchers attending HPV2014, the 29th International Papillomavirus Conference, which came to a close Monday in Seattle.

View story >


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.